Kowa Pharmaceuticals America Release: New Superiority Trial Showed LIVALO® (Pitavastatin) 4 mg Provided Significantly Greater LDL-C Reduction in HIV-Infected Adults With Dyslipidemia Versus Pravastatin 40 mg
3/7/2013 10:21:35 AM
More...
|
Kowa Pharmaceuticals America, Eli Lilly and Company (LLY) Release Results From a Pharmacokinetic Study
7/23/2012 7:54:22 AM
More...
|
John O'Hurley Teams Up With the National Lipid Association, Kowa Pharmaceuticals America and Eli Lilly and Company (LLY) to Announce Results of Landmark Statin USAGE Survey, Largest Known Survey of Cholesterol Patients
6/19/2012 9:06:23 AM
More...
|
Eli Lilly and Company (LLY) and Kowa Pharmaceuticals America Reveal Positive Results of PREVAIL US Study
5/31/2012 7:33:36 AM
More...
|
Kowa Pharmaceuticals America Release: New Study Data Published Assessing the Effect of LIVALO(R) vs. Crestor(R) on International Normalized Ratio on Steady-State Warfarin
2/13/2012 9:53:49 AM
More...
|
Kowa Pharmaceuticals America Release: New Data Showed Minimal Potential for Drug Interaction Between Cholesterol Drug LIVALO® and a Common Antiretroviral Therapy
7/18/2011 5:59:10 AM
More...
|
Cipher Pharmaceuticals (DND.TO) Achieves Sales Milestone For Lipofen(R); Triggering $1 Million From Kowa Pharmaceuticals America
7/7/2010 7:13:26 AM
More...
|
Kowa Pharmaceuticals America and Eli Lilly and Company (LLY) Announce U.S. Availability of LIVALO
6/21/2010 11:15:31 AM
More...
|
Eli Lilly and Company (LLY), Kowa Company and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement
12/23/2009 8:42:49 AM
More...
|
Kowa Pharmaceuticals America Announces the Divestment of CAMBIA(TM) and PRO-571
12/14/2009 9:41:18 AM
More...
|
|